Filing Details
- Accession Number:
- 0000950170-24-047031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-23 17:03:07
- Reporting Period:
- 2024-03-25
- Accepted Time:
- 2024-04-23 17:03:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1661998 | Q32 Bio Inc. | QTTB | Pharmaceutical Preparations (2834) | 473468154 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1916155 | Paul Alloway | Q32 Bio Inc. 830 Winter Street Waltham MA 02451 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-03-25 | 268 | $24.21 | 2,596 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of the RSUs.
- On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split.
Billionaire Hedge Funds
